Related Experiment Videos
Novel restriction fragment length polymorphisms in the cellular oncogene SEA
P R Koduru1, J C Goh, J D Broome
1Department of Laboratories, North Shore University Hospital, Manhasset, New York.
Hematologic Pathology
|January 1, 1992
Summary
Researchers identified new genetic variations in the SEA oncogene, crucial for distinguishing natural DNA differences from disease-related changes in leukemia and lymphoma patients.
Area of Science:
- Oncology
- Human Genetics
- Molecular Biology
Background:
- The SEA oncogene, located on chromosome 11q13, plays a role in certain cancers.
- Understanding genetic variations is key to differentiating normal polymorphisms from disease-associated mutations.
Purpose of the Study:
- To identify and characterize novel polymorphisms within the SEA oncogene.
- To investigate the frequency of these polymorphisms in healthy individuals and patients with hematological malignancies.
- To assess the utility of restriction fragment length polymorphism (RFLP) analysis for distinguishing gene rearrangements.
Main Methods:
- Restriction enzyme digestion (XbaI and SacI) of DNA.
- Analysis of DNA fragments using Southern blotting.
- Genotyping and allele frequency determination in diverse patient cohorts and controls.
Main Results:
- Novel XbaI and SacI polymorphisms were identified in the SEA gene.
- XbaI digestion revealed a three-allele system (A, B, and a rare allele).
- SacI digestion identified two primary genotypes, with further allelic variation (AA, BB, CC, DD) observed.
Conclusions:
- The identified SEA gene polymorphisms follow Mendelian inheritance patterns.
- Restriction mapping of oncogene DNA regions is vital for accurate diagnosis, distinguishing natural variations from pathogenic rearrangements.
- This research provides valuable genetic markers for hematological cancer studies.